69 related articles for article (PubMed ID: 16290264)
1. Dopamine D1 receptor-mediated toxicity in human SK-N-MC neuroblastoma cells.
Moussa CE; Tomita Y; Sidhu A
Neurochem Int; 2006 Feb; 48(3):226-34. PubMed ID: 16290264
[TBL] [Abstract][Full Text] [Related]
2. Differential cytotoxicity of human wild type and mutant alpha-synuclein in human neuroblastoma SH-SY5Y cells in the presence of dopamine.
Moussa CE; Wersinger C; Tomita Y; Sidhu A
Biochemistry; 2004 May; 43(18):5539-50. PubMed ID: 15122920
[TBL] [Abstract][Full Text] [Related]
3. Persistent activation of the dopamine D1 receptor contributes to prolonged receptor desensitization: studies with A-77636.
Lin CW; Bianchi BR; Miller TR; Stashko MA; Wang SS; Curzon P; Bednarz L; Asin KE; Britton DR
J Pharmacol Exp Ther; 1996 Mar; 276(3):1022-9. PubMed ID: 8786531
[TBL] [Abstract][Full Text] [Related]
4. Dopamine D(1) receptor facilitation of depolarization-induced release of gamma-amino-butyric acid in rat striatum is mediated by the cAMP/PKA pathway and involves P/Q-type calcium channels.
Arias-Montaño JA; Floran B; Floran L; Aceves J; Young JM
Synapse; 2007 May; 61(5):310-9. PubMed ID: 17318879
[TBL] [Abstract][Full Text] [Related]
5. Histamine H3 receptor activation inhibits dopamine D1 receptor-induced cAMP accumulation in rat striatal slices.
Sánchez-Lemus E; Arias-Montaño JA
Neurosci Lett; 2004 Jul; 364(3):179-84. PubMed ID: 15196671
[TBL] [Abstract][Full Text] [Related]
6. Adenosine A1 receptor-mediated inhibition of dopamine release from rat striatal slices is modulated by D1 dopamine receptors.
O'Neill C; Nolan BJ; Macari A; O'Boyle KM; O'Connor JJ
Eur J Neurosci; 2007 Dec; 26(12):3421-8. PubMed ID: 18052983
[TBL] [Abstract][Full Text] [Related]
7. Dopaminergic and adrenergic toxicities on SK-N-MC human neuroblastoma cells are mediated through G protein signaling and oxidative stress.
Chan AS; Ng LW; Poon LS; Chan WW; Wong YH
Apoptosis; 2007 Jan; 12(1):167-79. PubMed ID: 17136323
[TBL] [Abstract][Full Text] [Related]
8. Regulation and expression of D-1, but not D-5, dopamine receptors in human SK-N-MC neuroblastoma cells.
Sidhu A
J Recept Signal Transduct Res; 1997 Sep; 17(5):777-84. PubMed ID: 9292777
[TBL] [Abstract][Full Text] [Related]
9. Dopamine D1 receptors co-distribute with N-methyl-D-aspartic acid type-1 subunits and modulate synaptically-evoked N-methyl-D-aspartic acid currents in rat basolateral amygdala.
Pickel VM; Colago EE; Mania I; Molosh AI; Rainnie DG
Neuroscience; 2006 Oct; 142(3):671-90. PubMed ID: 16905271
[TBL] [Abstract][Full Text] [Related]
10. Desensitization and re-sensitization of CGRP receptor function in human neuroblastoma SK-N-MC cells.
Pin SS; Xu C; Bahr BA
Eur J Pharmacol; 2007 Dec; 577(1-3):7-16. PubMed ID: 17825280
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of NQO1 protects human SK-N-MC neuroblastoma cells against dopamine-induced cell death.
Zafar KS; Inayat-Hussain SH; Siegel D; Bao A; Shieh B; Ross D
Toxicol Lett; 2006 Oct; 166(3):261-7. PubMed ID: 16978807
[TBL] [Abstract][Full Text] [Related]
12. Effects of SKF-38393, a dopamine D1 receptor agonist on expression of amphetamine-induced behavioral sensitization and expression of immediate early gene arc in prefrontal cortex of rats.
Moro H; Sato H; Ida I; Oshima A; Sakurai N; Shihara N; Horikawa Y; Mikuni M
Pharmacol Biochem Behav; 2007 May; 87(1):56-64. PubMed ID: 17499349
[TBL] [Abstract][Full Text] [Related]
13. Activation of phosphatidylinositol-linked novel D1 dopamine receptors inhibits high-voltage-activated Ca2+ currents in primary cultured striatal neurons.
Ma LQ; Liu C; Wang F; Xie N; Gu J; Fu H; Wang JH; Cai F; Liu J; Chen JG
J Neurophysiol; 2009 May; 101(5):2230-8. PubMed ID: 19225177
[TBL] [Abstract][Full Text] [Related]
14. Topographical resolution of jaw movements mediated by cyclase- vs. non-cyclase-coupled dopamine D(1)-like receptors: studies with SK&F 83822.
Fujita S; Lee J; Kiguchi M; Uchida T; Cools AR; Waddington JL; Koshikawa N
Eur J Pharmacol; 2006 May; 538(1-3):94-100. PubMed ID: 16682023
[TBL] [Abstract][Full Text] [Related]
15. Repeated administration of a dopamine D1 receptor agonist reverses the increased proportions of striatal dopamine D1High and D2High receptors in methamphetamine-sensitized rats.
Shuto T; Seeman P; Kuroiwa M; Nishi A
Eur J Neurosci; 2008 May; 27(10):2551-7. PubMed ID: 18489579
[TBL] [Abstract][Full Text] [Related]
16. Extracellular dopamine induces the oxidative toxicity of SH-SY5Y cells.
Jiang Y; Pei L; Li S; Wang M; Liu F
Synapse; 2008 Nov; 62(11):797-803. PubMed ID: 18720420
[TBL] [Abstract][Full Text] [Related]
17. The atypical dopamine D1 receptor agonist SKF 83959 induces striatal Fos expression in rats.
Wirtshafter D; Osborn CV
Eur J Pharmacol; 2005 Dec; 528(1-3):88-94. PubMed ID: 16324697
[TBL] [Abstract][Full Text] [Related]
18. Loss of synaptic D1 dopamine/N-methyl-D-aspartate glutamate receptor complexes in L-DOPA-induced dyskinesia in the rat.
Fiorentini C; Rizzetti MC; Busi C; Bontempi S; Collo G; Spano P; Missale C
Mol Pharmacol; 2006 Mar; 69(3):805-12. PubMed ID: 16365282
[TBL] [Abstract][Full Text] [Related]
19. Modulation by D1 and D2 dopamine receptors of ATP-induced release of intracellular Ca2+ in cultured rat striatal neurons.
Rubini P; Engelhardt J; Wirkner K; Illes P
Neurochem Int; 2008 Jan; 52(1-2):113-8. PubMed ID: 17664020
[TBL] [Abstract][Full Text] [Related]
20. Induction of GADD45 and GADD153 in neuroblastoma cells by dopamine-induced toxicity.
Stokes AH; Freeman WM; Mitchell SG; Burnette TA; Hellmann GM; Vrana KE
Neurotoxicology; 2002 Dec; 23(6):675-84. PubMed ID: 12520757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
